8-K: Kodak Reports Mixed 2024 Financial Results: Net Income Up, Revenue and EBITDA Down

Eastman Kodak Company reports increased net income but decreased revenue and operational EBITDA for the full year 2024, alongside fourth-quarter improvements in gross profit and EBITDA.

Summary

• Eastman Kodak Company reported its fourth quarter and full year 2024 financial results on March 17, 2025.
• For Q4 2024, consolidated revenues were $266 million, a decrease of 3 percent compared to $275 million in Q4 2023.
• Gross profit for Q4 2024 increased by 9 percent to $51 million, compared to $47 million in the same period last year.
• The gross profit percentage for Q4 2024 was 19 percent, up from 17 percent in Q4 2023.
• GAAP net income for Q4 2024 was $26 million, a significant increase of 420 percent from $5 million in Q4 2023.
• Operational EBITDA for Q4 2024 increased by 350 percent to $9 million, compared to $2 million in Q4 2023.
• For the full year 2024, consolidated revenues were $1.043 billion, a decrease of 7 percent compared to $1.117 billion in 2023.
• Gross profit for the full year 2024 decreased by 3 percent to $203 million, compared to $210 million in the previous year.
• The gross profit percentage for the full year 2024 remained flat at 19 percent.
• GAAP net income for the full year 2024 increased by 36 percent to $102 million, compared to $75 million in 2023.
• Operational EBITDA for the full year 2024 decreased by 42 percent to $26 million, compared to $45 million in 2023.
• The company's year-end cash balance was $201 million, a decrease of $54 million from $255 million on December 31, 2023.

Sentiment

Score: 6

Explanation: The sentiment is mixed. While net income increased, revenue and EBITDA decreased. The company is making strategic investments, but faces challenges in a competitive market.

Positives

• Q4 2024 saw a significant increase in GAAP net income, rising by 420 percent.
• Operational EBITDA for Q4 2024 increased by 350 percent.
• Full year 2024 GAAP net income increased by 36 percent.
• The film business is experiencing growth, leading to investments in additional capacity.
• The tariff petition process has improved market conditions for Kodak's plates business.
• Brand licensing provided a cash boost of $40 million in Q1 2024.

Negatives

• Consolidated revenues for Q4 2024 decreased by 3 percent.
• Full year 2024 consolidated revenues decreased by 7 percent.
• Operational EBITDA for the full year 2024 decreased by 42 percent.
• The year-end cash balance decreased by $54 million compared to the previous year.

Risks

• The company's ability to improve and sustain its operating structure, cash flow, and profitability is a risk.
• Achieving strategic objectives, cash forecasts, and projected growth is subject to uncertainty.
• Obtaining additional or alternate financing if needed poses a risk.
• Fluctuations in foreign currency exchange rates, commodity prices, interest rates, and tariff rates could impact results.
• The global economic environment, including inflationary pressures and geopolitical issues, presents challenges.
• Competition from larger, well-financed industry participants is a risk.
• Supply chain disruptions and the availability of raw materials and components from single or limited sources of supply could adversely affect operations.
• The company's ability to comply with covenants in its credit facilities is a risk.
• Anticipating technology and industry trends and developing and marketing new products and solutions is subject to uncertainty.
• Managing, defending, and resolving current and legacy claims without incurring material losses or disruptions is a risk.
• Force majeure events, cyberattacks, or other data security incidents could harm operations.

Future Outlook

Kodak will continue to improve efficiency through automation and support customers with industry-leading solutions. The company will focus on growth areas and converting historical investments into long-term returns.

Management Comments

• Kodaks core businesses performed as expected in 2024, as we continued to execute our long-term plan which includes increasing operational efficiency, shedding unprofitable business and investing in growth, said Jim Continenza, Kodaks Executive Chairman and CEO.
• The Companys revenue for the year reflects a decline but is in line with expectations as we continue to concentrate on delivering improved gross profit, said David Bullwinkle, Kodaks CFO.
• In the next year, we continue to focus on our growth areas and converting our historical investments into returns for the long term, said David Bullwinkle, Kodaks CFO.

Industry Context

Kodak's focus on commercial print and advanced materials & chemicals aligns with the broader industry trend of companies specializing in niche markets to drive growth. The investment in a new cGMP facility for pharmaceutical products reflects a diversification strategy seen among traditional manufacturing companies.

Comparison to Industry Standards

• Comparing Kodak's performance to companies like Fujifilm (TYO: 4901) and Canon (TYO: 7751), which also have diversified portfolios including imaging, printing, and healthcare, reveals that Kodak's revenue decline is steeper than some of its peers.
• Fujifilm, for example, has managed to maintain relatively stable revenue through strategic acquisitions and a stronger focus on healthcare solutions.
• Kodak's operational EBITDA decline of 42% is significant and suggests challenges in operational efficiency compared to industry benchmarks.
• Companies like Ricoh (TYO: 7752), which focus on office printing solutions, have shown better EBITDA performance by streamlining operations and focusing on higher-margin services.
• The growth in Kodak's film business is a unique aspect, as most competitors have largely abandoned traditional film in favor of digital technologies; this niche growth could be a differentiating factor.

Stakeholder Impact

• Shareholders may be concerned about the decrease in revenue and operational EBITDA, but encouraged by the increase in net income.
• Employees may be affected by the termination of the Kodak Retirement Income Plan (KRIP).
• Customers can expect continued support and industry-leading solutions.
• Suppliers may see changes in demand based on Kodak's strategic shifts.
• Creditors will monitor Kodak's ability to service its debt.

Next Steps

• Begin production at the new cGMP facility for manufacturing regulated and unregulated pharmaceutical products.
• Continue investing in additional capacity to meet demand in the film business.
• Continue to improve efficiency through automation.
• Support customers with industry-leading solutions from all businesses.
• Settle the pension obligation with participants of the Kodak Retirement Income Plan (KRIP) and access any remaining plan surplus.

Key Dates